tanimilast: Clinical Trials

2 trials of tanimilast, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow tanimilast: new trials by email Literature Review of tanimilast trials Research Report on tanimilast

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD
CHF6001, Budesonide, Placebo - Chronic Obstructive Pulmonary Disease
Phase 2CompletedChiesi Farmaceutici S.p.A.11302016-12-152019-01-28
A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics
CHF6001, Placebo - Asthma
Phase 2CompletedChiesi Farmaceutici S.p.A.362012-10-012017-03-30

Conditions studied

Asthma (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Chiesi Farmaceutici S.p.A. (2)

Countries

United Kingdom (1)

Top investigators

Brian Leaker, MD (1)  ·  Dave Singh (1)  ·  Dave Singh, MD (1)  ·  Elizabeth Tranter, MD (1)

Results publications

PMID 32962709, PMID 37192443

NIH funding

2015 (1)